A screening model of anti-HIV non AZT cross resistance virostatics
- 31 December 1993
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 47 (10) , 461-462
- https://doi.org/10.1016/0753-3322(93)90344-k
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Preliminary analysis of the Concorde trialThe Lancet, 1993
- Use of evolutionary limitations of HIV-1 multidrug resistance to optimize therapyNature, 1993
- A Controlled Trial of Early versus Late Treatment with Zidovudine in Symptomatic Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1992
- Zidovudine resistance predicted by direct detection of mutations in DNA from HIV-infected lymphocytesAIDS, 1991
- Amino acridines action on Friend's retrovirus in relation to their molecular ionizationBiomedicine & Pharmacotherapy, 1989
- Multiple Mutations in HIV-1 Reverse Transcriptase Confer High-Level Resistance to Zidovudine (AZT)Science, 1989
- HIV with Reduced Sensitivity to Zidovudine (AZT) Isolated During Prolonged TherapyScience, 1989